Scinai Immunotherapeutics Ltd. (SCNI) SEC Filings — 2025

Filings

• Scinai Immunotherapeutics Holds Annual Shareholder Meeting — 6-K · Dec 23, 2025
• Scinai Immunotherapeutics Reports 9-Month 2025 Results — 6-K · Dec 2, 2025
• Scinai Immunotherapeutics Ltd. 6-K Filing — 6-K · Nov 13, 2025
• Scinai Immunotherapeutics Secures Israel Innovation Authority Grant — 6-K · Oct 6, 2025
• Scinai Immunotherapeutics Eyes Pincell srl Acquisition — 6-K · Sep 22, 2025
• Scinai Secures Up to $10M Equity Line with Yorkville — 6-K · Sep 11, 2025
• Scinai Immunotherapeutics Files 6-K Report — 6-K · Sep 2, 2025
• Scinai Immunotherapeutics Announces Funding and CDMO Growth — 6-K · Jun 12, 2025
• Scinai Immunotherapeutics Gets Italian Clearance for Pincell Acquisition — 6-K · Jun 5, 2025
• Scinai Immunotherapeutics Reports Q1 2025 Financials — 6-K · Jun 2, 2025
• Scinai Immunotherapeutics Files 2024 Annual Report — 20-F · May 7, 2025
• Scinai Immunotherapeutics to Acquire Rare Disease Firm Pincell — 6-K · Mar 27, 2025
• Scinai Immunotherapeutics Licenses VAX-24 Flu Vaccine — 6-K · Mar 24, 2025
• Scinai Immunotherapeutics Secures $10M Equity Line — 6-K · Mar 5, 2025
• Scinai Immunotherapeutics Secures $10M Equity Line — 6-K · Mar 4, 2025